Web-based System Enhances Mobile Plant Management
Siemens Comos Mobile Solutions 2.0 enhances mobile information management in globally distributed engineering projects and facilitates on-line collaboration.
Image courtesy of Siemens.
Siemens Comos Mobile Solutions 2.0 with a new graphical user interface (GUI) provides context-sensitive support functions and personalized dashboards. Another feature sends warnings in the event of deviations from target. All project stakeholders can navigate to relevant plant information with the aid of quicklinks, view documents, and submit project-related inquiries using a mobile device. The ability to upload external redlining PDFs to a tablet simplifies the process of document revision and enables clearly traceable change management at any time.
The system can also be used for project management, with features such as document check-in and check-out, and an integrated task management system. The need for manual data entries is reduced by the availability of editable web attributes, as suppliers make available the information directly in the Comos interface. This feature minimizes potential sources of error and loss of data, and enhances the efficiency of the engineering project, particularly when a large number of suppliers are involved.
Source: Siemens
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
The Role of Forced Degradation in Method Development, Manufacturability, and CMC Strategy
April 28th 2025Forced degradation studies are critical in biologics development, particularly for monoclonal antibodies (mAbs). These studies simulate long-term environmental stressors to uncover degradation pathways and ensure the stability of critical quality attributes (CQAs), aiding in robust chemistry, manufacturing, and controls (CMC) strategies and regulatory compliance.
Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
